BriaCell Therapeutics Corp. (TSX:BCT)
Canada flag Canada · Delayed Price · Currency is CAD
4.080
-0.140 (-3.32%)
Jun 27, 2025, 3:55 PM EDT

BriaCell Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 2015 - 2019
2619140130987
Upgrade
Market Cap Growth
-20.88%-86.55%7.66%32.65%1321.84%-49.84%
Upgrade
Enterprise Value
81710273737
Upgrade
Last Close Price
4.2615.45131.40125.7096.30143.25
Upgrade
PB Ratio
1.58-5.08-28.189.822.84-1.43
Upgrade
P/TBV Ratio
1.54--10.052.87-
Upgrade
Debt / Equity Ratio
----0.00-0.11
Upgrade
Quick Ratio
3.410.2111.8043.64102.880.01
Upgrade
Current Ratio
3.410.4914.9645.00103.810.07
Upgrade
Return on Equity (ROE)
-688.17%--619.75%-141.25%-114.78%-
Upgrade
Return on Assets (ROA)
-131.54%-126.11%-41.71%-18.99%-14.89%-509.24%
Upgrade
Return on Capital (ROIC)
-534.73%--444.01%-50.26%-35.58%-
Upgrade
Earnings Yield
-103.08%-35.14%-19.08%-26.45%-17.58%-78.18%
Upgrade
FCF Yield
-130.11%-180.31%-22.31%-12.30%-9.86%-24.59%
Upgrade
Buyback Yield / Dilution
-119.48%-5.35%-0.81%-242.82%-533.09%-23.16%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.